Skip to content

Self-monitoring of the Intraocular Pressure Versus Hospital-based Diurnal Monitoring

Can Self-monitoring of the Intraocular Pressure With the Icare HOME Make Hospital-based Diurnal Monitoring Redundant?

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04485897
Enrollment
25
Registered
2020-07-24
Start date
2020-11-26
Completion date
2024-08-01
Last updated
2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intraocular Pressure

Keywords

Glaucoma, self-monitoring, intraocular pressure, icare HOME, rebound tonometry

Brief summary

Glaucoma remains the leading cause of irreversible blindness worldwide. Glaucoma represents a group of diseases that lead to optic nerve damage and corresponding deterioration of the visual field. Elevated intraocular pressure remains the most important risk factor. Interestingly, glaucomatous damage sometimes occurs despite seemingly normal intraocular pressure. Recent studies suggest pressure peaks, which are missed under the current practice of spot intraocular measurements during office hours. In order to detect pressure peaks diurnal measurements are mandatory. Costly in-hospital diurnal measurements are the current standard. The primary study objective is to verify that self-tonometry at home can provide valuable information when looking for pressure peaks in patients with glaucoma.

Interventions

DEVICEicare HOME device (Icare Oy, Vanda, Finland)

icare HOME device versus hospital based measurements

Sponsors

Luzerner Kantonsspital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Informed consent * Subjects aged 18 and older * Glaucoma patients and healthy controls * Best corrected visual acuity \>0.1 * Astigmatism ≤ 3dpt. * Good compliance * Central corneal thickness (400-650μm) * Passed certification procedure (detailed description under: Measurements and procedures) * Therapeutic regimen unchanged throughout the past 30 days

Exclusion criteria

* History of ocular trauma * Corneal condition interfering with tonometry (keratoconus, corneal scaring) Visual acuity \<0.1 * Physical or mental disability interfering with self-tonometry (e.g. arthritis, Parkinson's disease) * Dry eye disease * Known or suspected non-compliance, drug or alcohol abuse * Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant * Pregnancy * Breastfeeding

Design outcomes

Primary

MeasureTime frameDescription
Comparison of an in- hospital diurnal pressure pattern of intraocular pressure to the pattern derived from self-tonometry using icare HOME in an outpatient setting.4 yearsStatistical methods for analysis of continuous method comparison data will be applied. The primary goal is to quantify the extent of agreement between two methods (Intraocular pressure measurement in-hospital and at home) and determine whether they sufficiently agree to be used interchangeably.

Secondary

MeasureTime frameDescription
variance of diurnal intraocular pressure4 yearsQuantitative evaluation of day to day variance of diurnal intraocular pressure measurement in an out-hospital setting in patients with open angle glaucoma, normal tension glaucoma and healthy controls
Influence of daily activities4 yearsInfluence of daily activities (sports, alcohol and water intake) on intraocular measurements at home (questionnaire)
Change of treatment4 yearsChange of treatment due to intraocular pressure peaks during hospitalisation and/or measurements at home

Countries

Switzerland

Contacts

Primary ContactRaphael Fritsche, MD
raphael.fritsche@luks.ch0041 205 33 76

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026